GHRS CIK: 1855129

GH Research PLC

  • Ireland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.3
FY22:
−26.2
FY23:
−33.3
FY24:
−42.3
FY25:
−43.6
Change from FY21 to FY25
millions USD
FY21:
−0.10
FY22:
−84.7
FY23:
−54.1
FY24:
65.1
FY25:
46.2
Change from FY21 to FY25
millions USD
FY21:
286
FY22:
0
FY23:
−0.20
FY24:
−0.30
FY25:
140
millions USD
FY21:
271
FY22:
−111
FY23:
−87.6
FY24:
22.5
FY25:
142
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.4
FY22:
−26.3
FY23:
−33.4
FY24:
−42.3
FY25:
−43.7

All amounts in millions USD Data source:SEC EDGAR